Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prasugrel Switching Study in Taiwanese ACS Patients
NCT03672097Phase 4Completed
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Oct 2018
- Primary completion
- Aug 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of prasugrel in acute coronary syndrome (ACS), sponsored by Daiichi Sankyo Co., Ltd.. Started Oct 2018; status: completed.
02
Drugs
prasugrel
03
Conditions
acute coronary syndrome (ACS)
Beyond the preview
Go deeper on NCT03672097.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03672097.